Emerging in the landscape of excess body fat therapy, retatrutide is a different strategy. Beyond many current medications, retatrutide operates as a double agonist, simultaneously engaging both glucagon-like peptide-1 (GLP-1) and glucose-responsive insulinotropic substance (GIP) binding sites. This simultaneous activation promotes various benefici… Read More